Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Үндсэн зохиолчид: Tangui Barré (Зохиогч), Fabrice Carrat (Зохиогч), Clémence Ramier (Зохиогч), Hélène Fontaine (Зохиогч), Vincent Di Beo (Зохиогч), Morgane Bureau (Зохиогч), Céline Dorival (Зохиогч), Dominique Larrey (Зохиогч), Elisabeth Delarocque-Astagneau (Зохиогч), Philippe Mathurin (Зохиогч), Fabienne Marcellin (Зохиогч), Ventzislava Petrov-Sanchez (Зохиогч), Carole Cagnot (Зохиогч), Patrizia Carrieri (Зохиогч), Stanislas Pol (Зохиогч), Camelia Protopopescu (Зохиогч), the ANRS/AFEF Hepather study group (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2022-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...